Back to top
Top
U.S. flag

An official website of the United States government

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

All eCQMs associated with: Proportion measure

Year Type CMS eCQM ID Measure Name
2022 EC CMS137v10 Initiation and Engagement of Alcohol and Other Drug Dependence Treatment
2023 EC CMS137v11 Initiation and Engagement of Substance Use Disorder Treatment
2024 EC CMS137v12 Initiation and Engagement of Substance Use Disorder Treatment
2022 EC CMS138v10 Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention
2023 EC CMS138v11 Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention
2024 EC CMS138v12 Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention
2022 EC CMS139v10 Falls: Screening for Future Fall Risk
2023 EC CMS139v11 Falls: Screening for Future Fall Risk
2024 EC CMS139v12 Falls: Screening for Future Fall Risk
2022 EC CMS142v10 Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes Care
2023 EC CMS142v11 Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes Care
2024 EC CMS142v12 Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes Care
2022 EC CMS143v10 Primary Open-Angle Glaucoma (POAG): Optic Nerve Evaluation
2023 EC CMS143v11 Primary Open-Angle Glaucoma (POAG): Optic Nerve Evaluation
2024 EC CMS143v12 Primary Open-Angle Glaucoma (POAG): Optic Nerve Evaluation
2022 EC CMS144v10 Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)
2023 EC CMS144v11 Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)
2024 EC CMS144v12 Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)
2022 EC CMS145v10 Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF less than 40%)
2023 EC CMS145v11 Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF less than or equal to 40%)